GlassScriptPhysician profile
Steven L Johnson
NPI 1477539245
$695.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $195 · 2021: $221 · 2022: $35.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $189.98 | 2019-2021 | |
| Boston Scientific Corporation | $144.66 | 2019-2022 | |
| Intuitive Surgical, INC. | $82.50 | 2021 | |
| Therapeuticsmd, INC. | $68.74 | 2019-2020 | |
| Allergan, INC. | $50.50 | 2019-2021 | |
| Coopersurgical, INC. | $46.33 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.82 | 2019 | |
| Duchesnay USA Incorporated | $24.12 | 2019 | |
| Merck Sharp & Dohme LLC | $14.51 | 2019 | |
| Becton, Dickinson and Company | $13.72 | 2019 | |
| Axonics, INC. | $13.44 | 2021 | |
| Hologic Sales and Service, LLC | $11.48 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.